The intersection of technology and innovation is driving significant advancements in various industries, from artificial intelligence to biotechnology. This news brief highlights key developments in these areas, showcasing the potential for growth, collaboration, and disruption.
Host a Side Event at Sessions: AI
TechCrunch is offering a unique opportunity for companies to host side events during its Sessions: AI Week in Berkeley. This platform allows businesses to amplify their brand and connect with over 1,000 AI experts and innovators. By hosting a side event, companies can receive exclusive promotions, listings on the TC Sessions: AI page, and more.
Cammra AI License Plate Recognition
FF Group has introduced Cammra AI, a cutting-edge license plate recognition system powered by five Convolutional Neural Networks embedded in Axis cameras. This technology delivers superior accuracy in all conditions and sets a new benchmark in AI-driven analytics. When integrated with third-party data and sensors, Cammra AI provides unparalleled insights for traffic management, security, and smart city solutions.
Pharmaceutical Companies Embracing AI
Pharmaceutical giants like J&J, Merck, and Eli Lilly are prioritizing upskilling in AI, recognizing its potential to boost productivity in drug development. Generative AI offers the promise of more quickly identifying compounds for new treatments and vaccines, accelerating drug development, and improving regulatory compliance. Companies like Eli Lilly are encouraging employees to use generative AI for tasks like drafting emails and memos, and even requiring senior leaders to obtain an AI certification.
Amazon VP Leaves Amid AI Shake-Up
Baskar Sridharan, Amazon's VP of AI/ML services and Data Services & Infrastructure, is leaving the company following a recent reorganization. This move is part of a bigger shake-up that created a new team within AWS, with Swami Sivasubramanian taking over as VP of AI and data. The Bedrock and AI organizations will now report to the AWS compute team.
Lila Sciences Aims for Scientific Superintelligence
Flagship Pioneering has launched Lila Sciences, a company backed by $200 million in seed funding. Lila Sciences aims to develop advanced AI that can power fully autonomous research labs, achieving 'scientific superintelligence' that can help scientists generate ideas and hypotheses. The company's platform has already achieved groundbreaking results in various scientific areas.
Should AI Investors Worry About Manus AI?
Manus AI, a Chinese startup, has raised concerns among AI investors with its claims of developing a fully autonomous AI agent. While some fear its abilities could pose a threat to human workers, others who have tested it claim that it still has significant flaws that need to be addressed before a wider rollout.
The 5 Best-Performing AI Stocks In The Last Year
To identify the best-performing AI stocks, we screened for companies with the largest one-year growth percentages and market capitalizations above $2 billion. The top 5 AI stocks are Palantir Technologies Inc., Upstart Holdings, Inc., Twilio Inc., SoundHound AI, Inc., and SAP SE.
Chinese Startup Claims to Have Built 'World's First' Fully Autonomous AI
Butterfly Effect, a Chinese firm, has developed Manus, a general-purpose AI capable of carrying out a vast range of tasks, including buying property, booking holidays, and developing video games. Manus is reportedly capable of outperforming the most advanced AI models from OpenAI.
All Lawyers Should Explore A.I: At SXSW, Legal Experts Weigh Benefits, Perils of Artificial Intelligence
Legal experts at SXSW discussed the benefits and perils of using AI in businesses and law firms. They agreed that guardrails need to be put in place to ensure responsible AI adoption. Companies must self-regulate and prioritize AI safety to avoid potential dangers.
Peter Thiel-Backed Palantir Plots AI Tech for Banks
Palantir, a military-focused data contractor, has partnered with TWG Group to create a joint venture that seeks to increase adoption of artificial intelligence in the financial space. The joint venture aims to provide financial institutions with a product to expedite AI adoption and integrate it at scale, alleviating cybersecurity concerns and outsourcing issues.
Key Takeaways
- Pharmaceutical companies are prioritizing upskilling in AI to boost productivity in drug development.
- Generative AI offers the promise of more quickly identifying compounds for new treatments and vaccines.
- Amazon's VP of AI/ML services and Data Services & Infrastructure is leaving the company following a recent reorganization.
- Lila Sciences aims to develop advanced AI that can power fully autonomous research labs.
- Manus AI, a Chinese startup, has raised concerns among AI investors with its claims of developing a fully autonomous AI agent.
- The top 5 AI stocks are Palantir Technologies Inc., Upstart Holdings, Inc., Twilio Inc., SoundHound AI, Inc., and SAP SE.
- Butterfly Effect has developed Manus, a general-purpose AI capable of carrying out a vast range of tasks.
- Legal experts at SXSW discussed the benefits and perils of using AI in businesses and law firms.
- Palantir has partnered with TWG Group to create a joint venture that seeks to increase adoption of artificial intelligence in the financial space.
Sources
- Host a Side Event at Sessions: AI
- Cammra AI license plate recognition (LPR) from FF Group
- How pharmaceutical companies are training their workers on AI
- Amazon VP who oversaw flagship AI product is leaving after a big shake-up
- With $200M in seed funding, Flagship-backed Lila Sciences touts ambitious AI vision
- Should AI investors worry about Manus AI? (NVDA:NASDAQ)
- The 5 Best-Performing AI Stocks In The Last Year
- Chinese startup says it’s built ‘world’s first’ fully autonomous AI
- All Lawyers Should Explore A.I: At SXSW, Legal Experts Weigh Benefits, Perils of Artificial Intelligence
- Peter Thiel-backed Palantir plots AI tech for banks